Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Women's Midlife Health

Articles

Sort by
Previous Page Page 1 of 2 Next Page
  1. Content type: Review

    To create a system where evidence based medicine can be applied to accommodate every woman’s needs by designing a contraceptive pathway that can be utilized by any healthcare provider, regardless of the patien...

    Authors: Chi-Son Kim, Deanna Tikhonov, Lena Merjanian and Adrian C. Balica

    Citation: Women's Midlife Health 2017 3:10

    Published on:

  2. Content type: Research

    Previous reports have noted that dehydroepiandrosterone-sulfate (DHEAS) increases prior to the final menstrual period (FMP) and remains stable beyond the FMP. How DHEAS concentrations correspond with other sex...

    Authors: Catherine Kim, Siobàn D. Harlow, Huiyong Zheng, Daniel S. McConnell and John F. Randolph Jr.

    Citation: Women's Midlife Health 2017 3:9

    Published on:

  3. Content type: Commentary

    Recently unintended pregnancies have been described as "a new kind of mid-life crisis." Given the high prevalence of unwanted or mistimed pregnancy in the US, we examined the sexual and reproductive health pat...

    Authors: Versie Johnson-Mallard, Elizabeth A. Kostas-Polston, Nancy Fugate Woods, Katherine E. Simmonds, Ivy M. Alexander and Diana Taylor

    Citation: Women's Midlife Health 2017 3:8

    Published on:

  4. Content type: Commentary

    This commentary discusses the limited availability of information on contraceptive preferences and unmet need for contraception among midlife women in both high and low income countries. Given that risk of pre...

    Authors: Siobán D. Harlow, Jennifer R. Dusendang, Michelle M. Hood and Nancy Fugate Woods

    Citation: Women's Midlife Health 2017 3:6

    Published on:

  5. Content type: Research

    Reproductive age may be a risk factor for vascular disease. Anti-Müllerian hormone (AMH) is produced by viable ovarian follicles and reflects reproductive age. We examined whether AMH concentrations were assoc...

    Authors: Catherine Kim, Yuanyuan Pan, Barbara H. Braffett, Valerie L. Arends, Michael W. Steffes, Hunter Wessells and Aruna V. Sarma

    Citation: Women's Midlife Health 2017 3:5

    Published on:

  6. Content type: Study protocol

    The Midlife Women’s Health Study (MWHS) was developed to address some of the gaps in knowledge regarding risk factors for hot flashes among generally healthy midlife women during their menopausal transition. T...

    Authors: Ayelet Ziv-Gal, Rebecca L. Smith, Lisa Gallicchio, Susan R. Miller, Howard A. Zacur and Jodi A. Flaws

    Citation: Women's Midlife Health 2017 3:4

    Published on:

  7. Content type: Research

    Patterns of symptom clustering in midlife women may suggest common underlying mechanisms or may identify women at risk of adverse health outcomes or, conversely, likely to experience healthy aging. This paper ...

    Authors: Siobán D. Harlow, Carrie Karvonen-Gutierrez, Michael R. Elliott, Irina Bondarenko, Nancy E. Avis, Joyce T. Bromberger, Maria Mori Brooks, Janis M. Miller and Barbara D. Reed

    Citation: Women's Midlife Health 2017 3:2

    Published on:

  8. Content type: Research

    The need for longitudinal, population-based studies to illuminate women’s experiences of symptoms during the menopausal transition motivated the development of the Seattle Midlife Women’s Health Study.

    Authors: Nancy Fugate Woods and Ellen Sullivan Mitchell

    Citation: Women's Midlife Health 2016 2:6

    Published on:

  9. Content type: Commentary

    A major unmet challenge in developing preventative treatment programs for osteoporosis is that the optimal timing of treatment remains unknown. In this commentary we make the argument that the menopausal trans...

    Authors: Karl J. Jepsen, Erin M. R. Bigelow, Melissa Ramcharan, Stephen H. Schlecht and Carrie A. Karvonen-Gutierrez

    Citation: Women's Midlife Health 2016 2:3

    Published on:

  10. Content type: Study protocol

    The Passo Fundo Cohort Study (PFS) is a population-based longitudinal observational study of pre-, peri-, and postmenopausal women that has been ongoing since 1995 in Passo Fundo, a city in southern Brazil. Th...

    Authors: Karen Oppermann, Verônica Colpani, Sandra C. Fuchs and Poli Mara Spritzer

    Citation: Women's Midlife Health 2015 1:12

    Published on:

  11. Content type: Review

    Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (scleroderma) preferentially affect women, and are characterized by systemic inflammation leadi...

    Authors: Wendy Marder, Évelyne Vinet and Emily C. Somers

    Citation: Women's Midlife Health 2015 1:11

    Published on:

  12. Content type: Review

    Female sexual dysfunction occurs frequently in midlife breast cancer survivors (BCS) and encompasses problems with sexual desire, interest, arousal, orgasm and genitopelvic pain. Although common, sexual proble...

    Authors: Susan M. Seav, Sally A. Dominick, Boris Stepanyuk, Jessica R. Gorman, Diana T. Chingos, Jennifer L. Ehren, Michael L. Krychman and H. Irene Su

    Citation: Women's Midlife Health 2015 1:9

    Published on:

  13. Content type: Review

    Canada’s Generation X is now entering the menopausal transition and pursuing effective therapy for bothersome vasomotor symptoms. They do so at a time when confusion about the safe and appropriate use of menop...

    Authors: Robert L. Reid and Bryden A. Magee

    Citation: Women's Midlife Health 2015 1:7

    Published on:

Previous Page Page 1 of 2 Next Page

World Contraception Day 2017

BMC is taking the opportunity to support World Contraception Day 2017 by sharing a selection of contraception and related articles and blog posts.

Upcoming conferences

October 2017
North American Menopause Society (NAMS)
11-14 October 2017
Philadelphia, PA, USA

American Society for Reproductive Medicine (ASRM)
28 October-1 November 2017
San Antonio, TX, USA

Advertisement